Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Medicated Skin Care in

Dermatologicals in Colombia

20 pages, Oct 2017

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Category growth driven by antifungals

Consumers’ increasing confidence in using OTC dermatologicals to treat minor ailments, along with less social stigma surrounding antifungal products, continued to have a positive impact on category sales in 2017. Dermatologicals recorded further solid growth, albeit slower than the review period average, with this being mainly due to the weak economic climate and a rise in value-added tax, which forced many Colombians to rein in their spending by reducing their purchases of non-basic goods or switching to more affordable brands.

Mixed performances from other dermatological categories

Hair loss treatments registered strong current value growth over much of the review period as alopecia became more common among both men and women. Despite the availability of various remedies, hair loss treatments remained an appealing choice due to their affordability compared to other alternatives.

COMPETITIVE LANDSCAPE

Foreign companies lead the way

The Mexican company Genomma Lab continued to lead dermatologicals in 2017, further strengthening its position thanks to brands such as Medicasp and Lomecan V, which registered further strong double-digit growth. These gains can be partly attributed to heavy advertising.

Bayer de Colombia loses share as Sanofi-Aventis Pharma grows

Bayer de Colombia continued to rank second but lost further share. Despite offering recognised brands such as Canesten and Gynocanesten, the company has been facing strong competition from Genomma Lab through heavy advertising and lower prices, which particularly appeal to consumers in the current economic climate.

Private label and generics

Private label remained an underdeveloped area, with this situation not expected to change significantly over the short term. Branded products continued to account for the largest share of value sales, with generics, however, becoming more common in topical antifungals and topical germicidals/antiseptics.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Medicated Skin Care Market Sample Report Medicated Skin Care Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Colombia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Colombia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Colombia market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Medicated Skin Care in Colombia?
What are the major brands in Colombia?
What are the most popular formats for acne treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Dermatologicals in Colombia - Category analysis

HEADLINES

PROSPECTS

Category growth driven by antifungals

Mixed performances from other dermatological categories

COMPETITIVE LANDSCAPE

Foreign companies lead the way

Bayer de Colombia loses share as Sanofi-Aventis Pharma grows

Private label and generics

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2012-2017
Table 2 Sales of Dermatologicals by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Dermatologicals: % Value 2013-2017
Table 4 LBN Brand Shares of Dermatologicals: % Value 2014-2017
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
Table 6 Forecast Sales of Dermatologicals by Category: Value 2017-2022
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022

Consumer Health in Colombia - Industry Overview

EXECUTIVE SUMMARY

Consumer health maintains positive growth in 2017 amidst an economic slowdown

Growing self-medication trend supported by switches

Foreign manufacturers command a major share of value sales

Chemists/pharmacies remains the leading distribution channel for consumer health

Increasing awareness of self-care and the ageing population to shape future sales

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 9 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2012-2017
Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

Summary 1 OTC: Switches 2016-2017

SOURCES

Summary 2 Research Sources

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Dermatologicals in Colombia

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Category growth driven by antifungals

Mixed performances from other dermatological categories

COMPETITIVE LANDSCAPE

Foreign companies lead the way

Bayer de Colombia loses share as Sanofi-Aventis Pharma grows

Private label and generics

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Dermatologicals in Colombia - Category analysis

HEADLINES

PROSPECTS

Category growth driven by antifungals

Mixed performances from other dermatological categories

COMPETITIVE LANDSCAPE

Foreign companies lead the way

Bayer de Colombia loses share as Sanofi-Aventis Pharma grows

Private label and generics

CATEGORY DATA

Consumer Health in Colombia - Industry Overview

EXECUTIVE SUMMARY

Consumer health maintains positive growth in 2017 amidst an economic slowdown

Growing self-medication trend supported by switches

Foreign manufacturers command a major share of value sales

Chemists/pharmacies remains the leading distribution channel for consumer health

Increasing awareness of self-care and the ageing population to shape future sales

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports